Retiros de la FDA: Adherall y Levotiroxina genéricos
FDA Recalls: Generic Adderall and Levothyroxine Multiple FDA recalls in July 2026 highlight systemic risks in generic drugs and dietary supplements, including a mix-up in generic Adderall XR capsules, subpotent levothyroxine tablets, and salmonella-contaminated moringa supplements. Independent reports reveal vulnerabilities …Leer más